Event Type
Disclosure
Mandatory
Variant
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Effective December 12, 2025, IGC Pharma, Inc. (the “Company”) amended its Amended and R
Financial Statements and Exhibits Exhibit No. Description 3.1 Articles of Amendment to the Articles of Incorporation of IGC Pharma, Inc., as filed with and acce